Marker Therapeutics News

Marker Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-New Enterprise Associates 16, L.P.(12.0%),NEA Partners 16, L.P.(12.0%), etc.

May 17 18:28 ET

Marker Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Lurier Eliot M

Jul 5, 2023 16:22 ET

Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Eansor Norman David

Jun 8, 2023 21:35 ET

Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Knobil Katharine

Jun 8, 2023 21:34 ET

Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Wilson John Robert

Jun 8, 2023 21:33 ET

Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ELMS STEVE

Jun 8, 2023 21:32 ET

Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Vera Juan

May 11, 2023 18:10 ET

Marker Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals(Amendment)-Aisling Capital IV, LP(5.46%),Steve Elms(5.46%), etc.

Mar 3, 2023 16:30 ET

Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities

Mar 1, 2023 16:52 ET

Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities

Mar 1, 2023 16:51 ET

Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities

Mar 1, 2023 16:50 ET

Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities

Mar 1, 2023 16:49 ET

Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities

Mar 1, 2023 16:48 ET

Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities

Mar 1, 2023 16:47 ET

Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities

May 26, 2022 16:12 ET

Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities

May 26, 2022 16:10 ET

Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities

May 26, 2022 16:10 ET

Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities

May 26, 2022 16:09 ET

Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities

May 26, 2022 16:08 ET

Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities

Mar 28, 2022 21:06 ET